The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling (Q43417842)

23 November 2017

The impact of CD34+ cell dose on engraftment after SCTs: personalized estimates based on mathematical modeling (English)

1 reference

23 November 2017

T Stiehl

1

1 reference

23 November 2017

A D Ho

series ordinal

2

1 reference

23 November 2017

A Marciniak-Czochra

series ordinal

3

1 reference

23 November 2017

language of work or name

English

0 references

publication date

23 September 2013

1 reference

Bone Marrow Transplantation

23 November 2017

1 reference

23 November 2017

49

1 reference

23 November 2017

1

1 reference

23 November 2017

30-37

1 reference

https://scigraph.springernature.com/pub.10.1038/bmt.2013.138

23 November 2017

0 references

cites work

Who is fit for allogeneic transplantation?

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

How I treat patients who mobilize hematopoietic stem cells poorly

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Factors affecting neutrophil recovery after autologous bone marrow-derived stem cell transplantation in patients with acute myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Challenges and advances in infection control of hematopoietic stem cell transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Invasive fungal infections in allogeneic and autologous stem cell transplant recipients: a single-center study of 166 transplanted patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Characteristics of and risk factors for pneumonia in patients with hematological malignancies developing fever after autologous blood stem cell transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

New approaches for improving engraftment after cord blood transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Selection of optimal alternative graft source: mismatched unrelated donor, umbilical cord blood, or haploidentical transplant

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Early neutrophil engraftment following autologous BMT provides a functional predictor of long‐term hematopoietic reconstitution

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Importance of day 21 BM chimerism in sustained neutrophil engraftment following double-unit cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Delayed platelet recovery after allogeneic transplantation: a predictor of increased treatment-related mortality and poorer survival.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

A computational model of human granulopoiesis to simulate the hematotoxic effects of multicycle polychemotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Modelling human granulopoiesis under poly-chemotherapy with G-CSF support.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

G-CSF treatment of canine cyclical neutropenia: a comprehensive mathematical model.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Dynamic hematological disease: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

A mathematical model of hematopoiesis: II. Cyclical neutropenia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

A novel dynamic model of hematopoietic stem cell organization based on the concept of within-tissue plasticity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Dynamic modeling of imatinib-treated chronic myeloid leukemia: functional insights and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: first results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantat

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Modeling of asymmetric cell division in hematopoietic stem cells--regulation of self-renewal is essential for efficient repopulation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Modeling of replicative senescence in hematopoietic development

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Replicative stress after allogeneic bone marrow transplantation: changes in cycling of CD34+CD90+ and CD34+CD90- hematopoietic progenitors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Polymorphisms in the TNFA gene promoter region show evidence of strong linkage disequilibrium with HLA and are associated with delayed neutrophil engraftment in unrelated donor hematopoietic stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Effects of spleen status on early outcomes after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Impact of HLA disparity in the graft-versus-host direction on engraftment in adult patients receiving reduced-intensity cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Factors associated with outcomes of unrelated cord blood transplant: guidelines for donor choice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Improving outcomes of cord blood transplantation: HLA matching, cell dose and other graft- and transplantation-related factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Donor-specific anti-HLA antibodies predict outcome in double umbilical cord blood transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Apheresis days required for harvesting CD34+ cells predicts hematopoietic recovery and survival following autologous transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Comparable kinetics of myeloablation between fludarabine/full-dose busulfan and fludarabine/melphalan conditioning regimens in allogeneic peripheral blood stem cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FBMT.2013.138

Cell-dose effect in circulating stem-cell autografting

21 January 2018

1 reference

12 December 2020

Infections in 100 cord blood transplantations: spectrum of early and late posttransplant infections in adult and pediatric patients 1996-2005

1 reference

12 December 2020

Effect of CD34 cell dose on hematopoietic reconstitution and outcome in 508 patients with multiple myeloma undergoing autologous peripheral blood stem cell transplantation

1 reference

12 December 2020

A randomised, prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies

1 reference

12 December 2020

Myeloid cell kinetics in response to haemopoietic growth factors

1 reference

12 December 2020

Hematopoietic recovery after allogeneic blood stem-cell transplantation compared with bone marrow transplantation in patients with hematologic malignancies

1 reference

12 December 2020

Risk factors for recurrence of invasive fungal infection during secondary antifungal prophylaxis in allogeneic hematopoietic stem cell transplant recipients

1 reference

12 December 2020

Factors influencing haemopoietic recovery following chemotherapy-mobilised autologous peripheral blood progenitor cell transplantation for haematological malignancies: a retrospective analysis of a 10-year single institution experience

1 reference

12 December 2020

Association between antibodies reactive with neutrophils, rate of neutrophil engraftment, and incidence of post-engraftment neutropenia following BMT

1 reference

12 December 2020

Homeostasis of telomere length rather than telomere shortening after allogeneic peripheral blood stem cell transplantation

1 reference

12 December 2020

Allogeneic hematopoietic transplantation of CD34+ selected cells from an HLA haplo-identical related donor. A long-term follow-up of 135 patients and a comparison of stem cell source between the bone marrow and the peripheral blood

1 reference

12 December 2020

Allogeneic peripheral blood stem cell transplantation in patients with advanced hematologic malignancies: a retrospective comparison with marrow transplantation

1 reference

12 December 2020

Human herpes virus 6 infection is a hallmark of cord blood transplant in adults and may participate to delayed engraftment: a comparison with matched unrelated donors as stem cell source

1 reference

12 December 2020

Outcomes among 562 recipients of placental-blood transplants from unrelated donors

1 reference

12 December 2020

Long-term follow-up of haploidentical hematopoietic stem cell transplantation without in vitro T cell depletion for the treatment of leukemia: nine years of experience at a single center

1 reference

12 December 2020

Delayed engraftment associated with splenomegaly in patients undergoing bone marrow transplantation for chronic myeloid leukaemia

1 reference

12 December 2020

An analysis of engraftment kinetics as a function of the CD34 content of peripheral blood progenitor cell collections in 692 patients after the administration of myeloablative chemotherapy

1 reference

12 December 2020

Patient cytomegalovirus seropositivity with or without reactivation is the most important prognostic factor for survival and treatment-related mortality in stem cell transplantation from unrelated donors using pretransplant in vivo T-cell depletion

1 reference

12 December 2020

The haploidentical option for high-risk haematological malignancies

1 reference

12 December 2020

Umbilical cord blood transplantation: review of factors affecting the hospitalized patient

1 reference

12 December 2020

Delayed recovery after autologous peripheral hematopoietic cell transplantation: potential effect of a high number of total nucleated cells in the graft

1 reference

12 December 2020

Identifiers

DOI

10.1038/BMT.2013.138

1 reference

Dimensions Publication ID

23 November 2017

0 references

1 reference